LONG-TERM EFFICACY AND SAFETY OF LANADELUMAB: FINAL RESULTS FROM THE HELP OPEN-LABEL EXTENSION STUDY

被引：0
|
作者：
Banerji, A.
Hao, J.
Yu, M.
Bernstein, J.
Johnston, D.
Riedl, M.
机构：
来源：
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY | 2020年 / 125卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
P150
引用
收藏
页码：S21 / S21
页数：1
相关论文
共 50 条
  • [31] LONG-TERM SAFETY AND EFFECTIVENESS OF LURASIDONE IN SCHIZOPHRENIA: RESULTS OF A 22 MONTH, OPEN-LABEL EXTENSION STUDY
    Pikalov, Andrei
    Correll, Christoph
    Cucchiaro, Josephine
    Silva, Robert
    Hsu, Jay
    Loebel, Antony
    SCHIZOPHRENIA RESEARCH, 2014, 153 : S178 - S178
  • [32] LONG-TERM SAFETY AND EFFECTIVENESS OF LURASIDONE IN SCHIZOPHRENIA: RESULTS OF A 22 MONTH, OPEN-LABEL EXTENSION STUDY
    Correll, C.
    Cucchiaro, J.
    Silva, R.
    Hsu, J.
    Pikalov, A.
    Loebel, A.
    EUROPEAN PSYCHIATRY, 2014, 29
  • [33] Long-Term Safety and Efficacy of Anifrolumab in Adults With Systemic Lupus Erythematosus: Results of a Phase II Open-Label Extension Study
    Chatham, W. Winn
    Furie, Richard
    Saxena, Amit
    Brohawn, Philip
    Schwetje, Erik
    Abreu, Gabriel
    Tummala, Raj
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 (05) : 837 - 847
  • [34] EFFICACY AND SAFETY OF LONG-TERM TREATMENT WITH LURASIDONE IN ADOLESCENTS WITH SCHIZOPHRENIA: RESULTS OF A 2-YEAR, OPEN-LABEL EXTENSION STUDY
    Correll, C.
    Goldman, R.
    Tocco, M.
    Pikalov, A.
    Deng, L.
    Loebel, A.
    Coghill, D.
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY, 2019, 53 : 105 - 105
  • [35] Safety and efficacy of tofacitinib for the treatment of patients with juvenile idiopathic arthritis: preliminary results of an open-label, long-term extension study
    Brunner, Hermine, I
    Akikusa, Jonathan D.
    Al-Abadi, Eslam
    Bohnsack, John F.
    Boteanu, Alina Lucica
    Chedeville, Gaelle
    Cuttica, Ruben
    De La Pena, Wendy
    Jung, Lawrence
    Kasapcopur, Ozgur
    Kobusinska, Katarzyna
    Schulert, Grant S.
    Neiva, Claudia
    Rivas-Chacon, Rafael
    Rodriguez, Juan Cruz Rizo
    Vazquez-Del Mercado, Monica
    Wagner-Weiner, Linda
    Weiss, Jennifer E.
    Wouters, Carine
    Posner, Holly
    Wouters, Ann
    Chang, Cheng
    White, Claire
    Kanik, Keith
    Liu, Shixue
    Martini, Alberto
    Lovell, Daniel J.
    Ruperto, Nicolino
    ANNALS OF THE RHEUMATIC DISEASES, 2024,
  • [36] Long-Term Efficacy and Safety of Romiplostim Treatment of Adult Patients with Chronic Immune Thrombocytopenia (ITP): Final Report from an Open-Label Extension Study
    Kuter, David J.
    Bussel, James B.
    Newland, Adrian
    Wasser, Jeffrey S.
    Lyons, Roger M.
    George, James N.
    Macik, Gail
    Nie, Kun
    Jun, Susie
    BLOOD, 2010, 116 (21) : 36 - 37
  • [37] Long-term safety of deutetrabenazine for the treatment of tardive dyskinesia: Results from an open-label, long-term study
    Anderson, K.
    Stamler, D.
    Davis, M.
    Factor, S.
    Hauser, R.
    Isojarvi, J.
    Jarskog, L.
    Jimenez-Shahed, J.
    Kumar, R.
    Ochudlo, S.
    Ondo, W.
    Fernandez, H.
    MOVEMENT DISORDERS, 2017, 32
  • [38] Long-Term Safety and Efficacy of Epratuzumab in the Treatment of Moderate-to-Severe Systemic Lupus Erythematosus: Results From an Open-Label Extension Study
    Wallace, D. J.
    Hobbs, K.
    Clowse, M. E. B.
    Petri, M.
    Strand, V.
    Pike, M.
    Merrill, J. T.
    Leszczynski, P.
    Neuwelt, C. M.
    Jeka, S.
    Houssiau, F.
    Keiserman, M.
    Ordi-Ros, J.
    Bongardt, S.
    Kilgallen, B.
    Galateanu, C.
    Kalunian, K.
    Furie, R.
    Gordon, C.
    ARTHRITIS CARE & RESEARCH, 2016, 68 (04) : 534 - 543
  • [39] Long-Term Safety and Efficacy of Risankizumab Treatment in Patients with Crohn's Disease: Results from the Phase 2 Open-Label Extension Study
    Ferrante, Marc
    Feagan, Brian G.
    Panes, Julian
    Baert, Filip
    Louis, Edouard
    Dewit, Olivier
    Kaser, Arthur
    Duan, W. Rachel
    Pang, Yinuo
    Lee, Wan-Ju
    Gustafson, Dawn
    Liao, Xiaomei
    Wallace, Kori
    Kalabic, Jasmina
    D'Haens, Geert R.
    JOURNAL OF CROHNS & COLITIS, 2021, 15 (12): : 2001 - 2010
  • [40] Dose tapering to withdrawal stage and long-term efficacy and safety of hetrombopag for the treatment of immune thrombocytopenia: Results from an open-label extension study
    Mei, Heng
    Liu, Xiaofan
    Li, Yan
    Zhou, Hu
    Feng, Ying
    Gao, Guangxun
    Cheng, Peng
    Huang, Ruibin
    Yang, Linhua
    Hu, Jianda
    Hou, Ming
    Yao, Yazhou
    Liu, Li
    Wang, Yi
    Wu, Depei
    Zhang, Liansheng
    Zheng, Changcheng
    Shen, Xuliang
    Hu, Qi
    Liu, Jing
    Jin, Jie
    Luo, Jianmin
    Zeng, Yun
    Gao, Sujun
    Zhang, Xiaohui
    Zhou, Xin
    Shi, Qingzhi
    Xia, Ruixiang
    Xie, Xiaobao
    Jiang, Zhongxing
    Gao, Li
    Bai, Yuansong
    Xiong, Junye
    Li, Runzi
    Zou, Jianjun
    Niu, Ting
    Yang, Renchi
    Hu, Yu
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2022, 20 (03) : 716 - 728
12345